Filing Details
- Accession Number:
- 0001401708-22-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-09 17:25:17
- Reporting Period:
- 2022-03-06
- Accepted Time:
- 2022-03-09 17:25:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401708 | Nanostring Technologies Inc | NSTG | Biological Products, (No Disgnostic Substances) (2836) | 200094687 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1576195 | M Joseph Beechem | 530 Fairview Avenue N Seattle WA 98109 | Svp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-07 | 3,741 | $0.00 | 82,635 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-03-07 | 2,764 | $0.00 | 85,399 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-08 | 2,968 | $33.06 | 82,431 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2022-03-06 | 25,380 | $0.00 | 25,380 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2022-03-07 | 3,741 | $0.00 | 3,741 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2022-03-07 | 2,764 | $0.00 | 2,764 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,380 | No | 4 | A | Direct | ||
| 3,742 | No | 4 | M | Direct | ||
| 5,529 | No | 4 | M | Direct |
Footnotes
- The reported shares were sold to cover the reporting person's tax liability in connection with the vesting of Restricted Stock Units ("RSUs").
- Each RSU represents a contingent right to receive one (1) share of Issuer's common stock.
- 1/3 of the RSUs vest on or following the first anniversary of March 5, 2022 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on or after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.
- 1/3 of the RSUs vest on the first market trading day following the first anniversary of March 5, 2020 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on the first market trading day on or after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.
- 1/3 of the RSUs vest on or following the first market trading day following the first anniversary of March 5, 2021 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on the first market trading day on or after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.
Billionaire Hedge Funds
